Ouch!! That hurts. Billions down the drain on a failed drug. To bad AbbVie bet on the wrong horse. They should probably lick their wounds and then give IPIX a $500MM cash infusion with some billions in milestone payments and then maybe a 10+ billion partnership once K is FDA approved. After about 7 or 8 years on the market K will get AbbVie back well into the green to make up for their mistake on the other drug.